Erin Lopata
Vice President, Director
Strategist and former access decision maker. Focus on specialty medications, orphan drugs, oncology therapies, and cell and gene therapies. Published expert on payer management and affordability strategies for treatment of rare disease. Sought-after specialist in formulary and utilization management with deep experience in integrated network delivery-health plan collaboration.
